Myeloma minute:Versus Placebo Maintenance Therapy Following
Publicado: Jue Ene 07, 2010 3:56 pm
ASH 2009: Philip McCarthy
Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events
Philip L. McCarthy, MD
Roswell Park Cancer Institute
Buffalo, NY
http://myeloma.org/ArticlePage.action?t ... goryId=451
Texto:
http://myeloma.org/ArticlePage.action?t ... 32&aTab=-1
Abrazos
Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events
Philip L. McCarthy, MD
Roswell Park Cancer Institute
Buffalo, NY
http://myeloma.org/ArticlePage.action?t ... goryId=451
Texto:
http://myeloma.org/ArticlePage.action?t ... 32&aTab=-1
Abrazos